Case study on peptic
ulcer disease
PRESENTED BY KRISHNA M 4TH PHARM D
SUBJECTIVE
A 3 – year old female patient was admitted with fever , coffee , ground vomiting and abdominal ,
Hemodynamically stable .
HISTORY OF PRESENT ILLNESS
H/O fever +
H/O coffee ground vomiting
H/O abdominal pain
H/O general malaise
H/O dehydration
PAST MEDICAL AND MEDICINE HISTORY
H/O upper respiratory infection
H/O allergy to cephalosporin , amoxicillin / clavulanic
DRUG CHART ( UPPER RESPIRATORY INFECTION )
IBUPROFEN 100MG
CLARITHROMYCIN 7.5MG/KG/DAY
FAMILY HISTORY
H/O PEPTIC ULCER
GENERAL EXAMINATION
Conscious oriented
BP 108/71
•Pulse 128
•Alert
•active
• playful
no clubbing
no lymphadenopathy
SYSTEMIC EXAMINATION
CVS –S1S2+
RS- BAE+
CNS- NFND
P/A- Soft
ENDOSCOPY : non bleeding gastric ulceration
LABORATORY INVESTIGATION
PARAMETERS OBSERVED VALUE REFERENCE VALUE
Haemoglobin 10.5g/dl 11.3-14.1g/dl
ESR 25mm/hr Upto 20mm/hr
HCT 28.1% 30-39%
RBC 3.95 million/mm³ 3.80- 5.20 million/mm³
Total WBC 20,000cells/cu.mm 6000-17,500 cells/cu.mm
Lymphocytes 12.3×109/l 1.0–13.5×109/l
Monocytes 1.5×109/l 0.1–1.5×109/l
Granulocytes 8.2x109/l 1.0–8.5×109/l
Lymphocytes 53.4% 47-77%
Monocytes 6.8% 2-10%
Granulocytes 39.8% 15-45%
Platelet 499,000/mm³ 150,000-450,000/mm³
MCV 75.2fl 77-108fl
MCH 26.0pg /cell 27-35pg/cell
MCHC 35.5g/dl 32-36g/dl
Blood sugar
RBS 82mg/dl 80-140mg/dl
RENAL PROFILE
Blood Urea 30mg/dl 10-50mg/dl
Serum Creatinine 1.0mg/dl 0.6-1.9mg/dl
URINE ANALYSIS
Colour Pale yellow
PH Acidic
Albumin Nil
RBC Nil
Sugar Nil
Puss cells 2-4HPF 5-10HPF
Epithelial cells 0-1/HPF 5-10/HPF
Cast crystals Nil
RA factor Negative
CRP Negative
FINAL ASSESSMENT
DIAGNOSIS
NSAIDS INDUCED PEPTIC ULCER DISEASE
TREATMENT PLAN
GOALS OF THEARPY
An intestinal infection marked by diarrhoea , cramps, nausea, vomiting and fever.
The goals of pharmacotherapy are to reduce morbidity, prevent complications, and provide
prophylaxis.
Probiotics are live microbial feeding supplements commonly used in the treatment and
prevention of acute diarrhea.
zinc supplementation may be effective in reducing the duration of diarrhea in children older than
6 months.
DRUG CHART
BRAND NAME GENERIC
NAME
DOSE ROUTE FRQ 1 2
Inj.Taxim Cefotaxime 250mg i.v 8th
hourly

t. dolo paracetamol 250 mg oral od 
t. esomeprazole esomeprazole 10mg / day oral od  
DRUG SUMMARY
Patient Discharge After 2 days of Adminisation
Pantoprazole
No drug drug intraction
DRUG DRUG INTRACTION
NO INTRACTION HAS BEEN FOUND
PATIENT COUNSELLING
DISEASED BASED COUNCELLING
Disease completely cured once patient complete drug plan completely .
IF any vomiting persist parents should immediately contact the doctor and stop the medication.
Give diet like protein , carbohydrate rich food in order to prevent dehydration.
DIET COUNSELLING
PATIENT SHOULD AVIOD SPICY FOODS .
PATIENT SHOULD NOT TAKE LARGE AMOUNT OF FOOD.
DURG BASED COUNSELLING
FOLLOW UP THE PRESCRICTION IN ORDER AVIOD PAIN , DISCOMFORT ETC..
ANY ADVERSE REACTION IMMEDIATELY STOP THE MEDICATION , IN ORDER TO PREVENT THE
TOXIC EFFECT .

Case study on peptic ulcer disease

  • 1.
    Case study onpeptic ulcer disease PRESENTED BY KRISHNA M 4TH PHARM D
  • 2.
    SUBJECTIVE A 3 –year old female patient was admitted with fever , coffee , ground vomiting and abdominal , Hemodynamically stable .
  • 3.
    HISTORY OF PRESENTILLNESS H/O fever + H/O coffee ground vomiting H/O abdominal pain H/O general malaise H/O dehydration
  • 4.
    PAST MEDICAL ANDMEDICINE HISTORY H/O upper respiratory infection H/O allergy to cephalosporin , amoxicillin / clavulanic DRUG CHART ( UPPER RESPIRATORY INFECTION ) IBUPROFEN 100MG CLARITHROMYCIN 7.5MG/KG/DAY
  • 5.
  • 6.
    GENERAL EXAMINATION Conscious oriented BP108/71 •Pulse 128 •Alert •active • playful no clubbing no lymphadenopathy
  • 7.
    SYSTEMIC EXAMINATION CVS –S1S2+ RS-BAE+ CNS- NFND P/A- Soft ENDOSCOPY : non bleeding gastric ulceration
  • 8.
  • 9.
    PARAMETERS OBSERVED VALUEREFERENCE VALUE Haemoglobin 10.5g/dl 11.3-14.1g/dl ESR 25mm/hr Upto 20mm/hr HCT 28.1% 30-39% RBC 3.95 million/mm³ 3.80- 5.20 million/mm³ Total WBC 20,000cells/cu.mm 6000-17,500 cells/cu.mm Lymphocytes 12.3×109/l 1.0–13.5×109/l Monocytes 1.5×109/l 0.1–1.5×109/l Granulocytes 8.2x109/l 1.0–8.5×109/l Lymphocytes 53.4% 47-77% Monocytes 6.8% 2-10% Granulocytes 39.8% 15-45% Platelet 499,000/mm³ 150,000-450,000/mm³ MCV 75.2fl 77-108fl MCH 26.0pg /cell 27-35pg/cell MCHC 35.5g/dl 32-36g/dl
  • 10.
    Blood sugar RBS 82mg/dl80-140mg/dl RENAL PROFILE Blood Urea 30mg/dl 10-50mg/dl Serum Creatinine 1.0mg/dl 0.6-1.9mg/dl URINE ANALYSIS Colour Pale yellow PH Acidic Albumin Nil RBC Nil Sugar Nil Puss cells 2-4HPF 5-10HPF Epithelial cells 0-1/HPF 5-10/HPF Cast crystals Nil RA factor Negative CRP Negative
  • 11.
  • 12.
  • 13.
    GOALS OF THEARPY Anintestinal infection marked by diarrhoea , cramps, nausea, vomiting and fever. The goals of pharmacotherapy are to reduce morbidity, prevent complications, and provide prophylaxis. Probiotics are live microbial feeding supplements commonly used in the treatment and prevention of acute diarrhea. zinc supplementation may be effective in reducing the duration of diarrhea in children older than 6 months.
  • 14.
  • 15.
    BRAND NAME GENERIC NAME DOSEROUTE FRQ 1 2 Inj.Taxim Cefotaxime 250mg i.v 8th hourly  t. dolo paracetamol 250 mg oral od  t. esomeprazole esomeprazole 10mg / day oral od  
  • 16.
    DRUG SUMMARY Patient DischargeAfter 2 days of Adminisation Pantoprazole No drug drug intraction
  • 17.
    DRUG DRUG INTRACTION NOINTRACTION HAS BEEN FOUND
  • 18.
  • 19.
    DISEASED BASED COUNCELLING Diseasecompletely cured once patient complete drug plan completely . IF any vomiting persist parents should immediately contact the doctor and stop the medication. Give diet like protein , carbohydrate rich food in order to prevent dehydration.
  • 20.
    DIET COUNSELLING PATIENT SHOULDAVIOD SPICY FOODS . PATIENT SHOULD NOT TAKE LARGE AMOUNT OF FOOD.
  • 21.
    DURG BASED COUNSELLING FOLLOWUP THE PRESCRICTION IN ORDER AVIOD PAIN , DISCOMFORT ETC.. ANY ADVERSE REACTION IMMEDIATELY STOP THE MEDICATION , IN ORDER TO PREVENT THE TOXIC EFFECT .